论文部分内容阅读
生脉注射液是在中医经典古方生脉散的基础上研制而成,由人参、麦冬、五味子组成,有益气养阴复脉固脱的作用。现代药理研究结果表明,生脉散具有抗中毒性休克、抗失血性休克、调节血压和强心作用;能增加冠脉血流量、改善心肌缺血、调整心肌代谢、提高耐缺氧能力;能降低血液粘度和血小板聚集、抑制血栓形成,改善血液流变性和微循环;还能提高机体活力和肝脏能量代谢;显著对抗毛细血管通透性的增高而具非特异性抗炎作用;显著提高内源性皮质激素水平;激活吞噬功能,抑制 IgE 介导的体液免疫而显著提高机体的细胞免疫功能等。
Shengmai injection is developed on the basis of traditional Chinese medical ancient Shengmaisan. It is composed of ginseng, Ophiopogon japonicus and Schisandra. It is beneficial to qi and nourishing yin. Modern pharmacological studies have shown that Shengmaisan has anti-toxic shock, anti-hemorrhagic shock, regulation of blood pressure and cardiac function; can increase coronary blood flow, improve myocardial ischemia, adjust myocardial metabolism, and improve resistance to hypoxia; Reduces blood viscosity and platelet aggregation, inhibits thrombosis, improves blood rheology and microcirculation, improves body vitality and liver energy metabolism, significantly counteracts increased capillary permeability and has a non-specific anti-inflammatory effect, significantly improves endogenous Corticosteroid levels; activation of phagocytosis, inhibition of IgE-mediated humoral immunity, and significantly improve the body’s cellular immune function.